Both President Donald Trump and Sen. Rand Paul (R-Ky.) signaled last week that executive action was in the works that would give these plans a boost.
En la ciudad hay un solo centro de trauma, especializado en tratar a pacientes con lesiones severas producto de disparos, caídas o accidentes automovilísticos. Qué pasa a nivel nacional
Hospitals view adding trauma care as a potential profit tool, but experts say having more centers does not necessarily improve the system’s ability to respond to a mass casualty event.
The fate of the Affordable Care Act’s individual insurance marketplaces remains in play as state insurance commissioners take a central role in the debate.
The FDA granted approval for Spinraza in late December for use on children and adults with spinal muscular atrophy. Insurance coverage is mostly focused on infants and children.
Kaiser Health News examines the role of PBMs in the prescription drug-pricing pipeline.
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
Republican senators are warming to the idea of a scaled-back plan that would delete the Affordable Care Act’s individual and employer mandates but leave the rest of law generally intact. But this approach has caused difficulties in the past.
During another day of fast-moving developments, Senate Republicans signaled their intent to attempt to bring an updated repeal-and-delay bill to the floor for a vote next week.
The failure this week of the U.S. Senate’s ACA repeal effort was one more twist in the ongoing political drama that has complicated routine rate setting for insurers and state officials.